Bank Julius Baer & Co. Ltd, Zurich Bio Rad Laboratories, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$708.84 - $794.68 $1.08 Million - $1.21 Million	-1,518 Reduced 87.49%	217 $164,000
Q3 2021 Nov 12, 2021	BUY	$657.71 - $825.77 $421,592 - $529,318	641 Added 58.59%	1,735 $1.29 Million
Q2 2021 Jul 23, 2021	BUY	$576.64 - $649.04 $471,691 - $530,914	818 Added 296.38%	1,094 $705,000
Q1 2021 May 10, 2021	SELL	$547.01 - $662.35 $858,805 - $1.04 Million	-1,570 Reduced 85.05%	276 $158,000
Q4 2020 Feb 24, 2021	SELL	$510.68 - $643.45 $294,151 - $370,627	-576 Reduced 23.78%	1,846 $1.08 Million
Q4 2020 Feb 12, 2021	BUY	$510.68 - $643.45 $670,522 - $844,849	1,313 Added 118.39%	2,422 $1.08 Million
Q3 2020 Nov 10, 2020	BUY	$454.43 - $535.6 $442,160 - $521,138	973 Added 715.44%	1,109 $572,000
Q2 2020 Aug 12, 2020	BUY	$334.87 - $493.06 $45,542 - $67,056	136 New	136 $61,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.19B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.